JMP


JMP’s Michael King Neutral on Ariad Pharmaceuticals, Inc. (ARIA) Despite Full FDA Approval for Iclusig

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) released yesterday morning the FDA’s decision approving the firm’s pipeline drug Iclusig (ponatinib), used in the treatment of chronic …

Analysts Sing the Praises of Two Tech Giants: Facebook Inc (FB) and Netflix, Inc. (NFLX)

Analysts are outlining bullish forecasts for both Facebook Inc (NASDAQ:FB) and Netflix, Inc. (NASDAQ:NFLX).

JMP Encouraged on Endo International plc – Ordinary Shares (ENDP) Following Statistically Significant Phase 2B Cellulite Data Results

JMP analyst Donald Ellis is encouraged on Endo International plc – Ordinary Shares (NASDAQ:ENDP) after the biotech firm’s pipeline drug Xiaflex, used to …

Biotech Talk: Valeant Pharmaceuticals Intl Inc (VRX) and Endo International (ENDP)

Amid President Elect Donald Trump’s victory, stocks in the biotech sector are on an upturn now that the Clinton Administration will not be …

Internet Spotlight: JMP Mixed On Facebook Inc (FB) And Yelp Inc (YELP)

Facebook Inc (NASDAQ:FB) and Yelp Inc (NYSE:YELP) reported third-quarter financial earnings last week, and JMP analyst Ronald Josey commends the two internet players for robust …

JMP Dives in on Cisco Systems, Inc. (CSCO) Following Investor Meeting

JMP analyst Erik Suppiger is out with a research report on Cisco Systems, Inc. (NASDAQ:CSCO) after hosting an investor meeting with vice president …

Buyout Rumors: Analysts Dive in on Twitter Inc (TWTR) and Imperva Inc (IMPV)

Twitter Inc Twitter Inc (NYSE:TWTR) shares soared nearly 20% today on the back of rumors that the social-media giant has initiated talks with several …